By: Chris Hannay
Group was formed to advise Ottawa on how to support the industry and ensure access to medication in the midst of developments such as USMCA talks
Chris Hannay is an Independent Business Reporter at The Globe and Mail. He covers a range of topics including business, small and medium enterprises, arts, architecture, and design, with a particular focus on healthcare administration, patient care, and public health. Chris has been featured in The Globe and Mail, St. Albert Gazette, and World Wealth Journal.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Canada (National)
Not enough data
Chris Hannay appears most responsive to pitches tied to Canada’s health system, especially those involving regulation, drug supply, and operational issues affecting providers and patients. He often covers policy changes, bottlenecks, and market shifts with a practical, data-backed angle.
He would likely value sources that can speak to real-world impact, such as how a rule change, backlog, shortage, or funding decision affects access, timelines, costs, or care delivery. Timely developments with concrete numbers or direct on-the-ground implications should stand out.
His coverage is national in scope, so pitches should be framed around Canada-wide relevance.
This information evolves through artificial intelligence and human feedback. Improve this profile .